Related Experiment Video

Updated: Jul 15, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA)

N Z Haque1, S L Davis, C L Manierski

  • 1Henry Ford Health System, Detroit, MI, USA.

International Journal of Antimicrobial Agents
|April 13, 2007
PubMed

Insights

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA) is increasingly seen in urban settings, particularly among injection drug users. This highlights the need for heightened clinical awareness and tailored prevention strategies for this evolving pathogen.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Infective endocarditis (IE) is a serious infection of the heart's inner lining.
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen, with the USA300 strain becoming increasingly prevalent.
  • Injection drug use is a known risk factor for developing IE.

Observation:

  • This study details seven cases of IE attributed to USA300 MRSA at an urban academic medical center.
  • All affected patients were identified as injection drug users.
  • The isolates were confirmed as USA300-type MRSA using pulsed-field gel electrophoresis.

Findings:

  • Five cases involved right-sided endocarditis, and two involved left-sided endocarditis.
  • Patients received prolonged antimicrobial therapy, averaging 23 days in-hospital and 55 days total.
  • Complications included heart failure, requiring valve replacement in one case, and mortality in that same patient.

Implications:

  • The rising prevalence of USA300 MRSA necessitates increased clinical vigilance for IE, especially in at-risk populations.
  • Understanding the spectrum of illness associated with USA300 MRSA IE is crucial for effective management.
  • Enhanced prevention strategies are needed to address the growing threat of this virulent MRSA strain.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...